Assessment of inter-individual variability in predicted phenytoin clearance (original) (raw)
Different pharmacokinetic parameters of phenytoin in Iranian Outpatients: Need to Optimize the current Dosage administration
Ebrahim Salehifar
Iranian Journal of …, 2010
View PDFchevron_right
In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods
Sami Haddad
Journal of Pharmaceutical Sciences, 2012
View PDFchevron_right
MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics
David Ingram
British Journal of Clinical Pharmacology, 1980
View PDFchevron_right
Predicting individual phenytoin dosage
Ferenc Follath
Journal of Pharmacokinetics and Biopharmaceutics, 1981
View PDFchevron_right
A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study
Andrew McLachlan
CPT: Pharmacometrics & Systems Pharmacology
View PDFchevron_right
Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: II. Absolute Bioavailability of Intravenous Phenytoin Prodrug at Therapeutic Phenytoin Serum Concentrations Determined by Double-Stable Isotope Technique
Hamid Davoudi
The Journal of Clinical Pharmacology, 1993
View PDFchevron_right
Prediction of hepatic microsomal intrinsic clearance and human clearance values for drugs
Katarina Nikolic
Journal of Molecular Graphics and Modelling, 2009
View PDFchevron_right
Therapeutic drug monitoring of phenytoin needs vigilance: An individualized PD response is variable
IJRPP Journal
View PDFchevron_right
Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective
Neil Parrott
Clinical Pharmacology & Therapeutics, 2020
View PDFchevron_right
Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observations
Khaled Abduljalil
Drug metabolism and disposition: the biological fate of chemicals, 2014
View PDFchevron_right
Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs
Marjoleen Nijsen
Drug metabolism and disposition: the biological fate of chemicals, 2007
View PDFchevron_right
Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs
Sami Haddad
Journal of Pharmaceutical Sciences, 2012
View PDFchevron_right
Phenytoin: A Guide to Therapeutic Drug Monitoring
sertini mrp
View PDFchevron_right
Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview
Grace Davis
Current Pharmacology Reports
View PDFchevron_right
Utility of Minimal Physiologically-Based Pharmacokinetic (mPBPK) Models for Assessing Fractional Distribution, Oral Absorption and Series-Compartment Models of Hepatic Clearance
William Jusko
Drug Metabolism and Disposition, 2023
View PDFchevron_right
Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting
Robert A Gross
Seizure, 2017
View PDFchevron_right
PHARMACOKINETICS- CLINICAL PHARMACOLOGY
magendira mani vinayagam
View PDFchevron_right
Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro , Imaging and Physiologically Based Pharmacokinetic Modeling Approaches
Neil Parrott
Clinical Pharmacology & Therapeutics, 2018
View PDFchevron_right
The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement
Jan Snoeys
Expert Opinion on Drug Metabolism & Toxicology, 2014
View PDFchevron_right
A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Neil Parrott
Clinical Pharmacokinetics, 2006
View PDFchevron_right
Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data
brian houston
Drug Metabolism and Disposition, 2011
View PDFchevron_right
Pharmacokinetics : Interactions of New Drugs and the Human Body
Barry Bleidt
Drugs and the Pharmaceutical Sciences, 1996
View PDFchevron_right
Accuracy of Two Equations in Determining Normalized Phenytoin Concentrations
Laurie Mauro
DICP, 1989
View PDFchevron_right
Evaluation of a Physiologically-Based Pharmacokinetic Approach for Simulating the First-Time-In-Animal Study
Hugh Barton
Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, 2005
View PDFchevron_right
Basic pharmacokinetics Soraya Dhillon and Kiren Gill
Abdul Kader Mohiuddin
View PDFchevron_right
Commentary on “physiologically based pharmacokinetic modeling as a tool for drug development”
Thomas Ludden
Journal of Pharmacokinetics and Biopharmaceutics, 1995
View PDFchevron_right
Applied Clinical Pharmacokinetics
Brian Byrd
View PDFchevron_right
Impact on in vitro-in vivo extrapolation of drug clearance
Wichittra Tassaneeyakul
2012
View PDFchevron_right
Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal study
italo poggesi
European Journal of Pharmaceutical Sciences, 2007
View PDFchevron_right
Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
Penny Oxley
Clinical Pharmacokinetics, 2011
View PDFchevron_right
Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation
brian houston
Drug Metabolism and Disposition, 2020
View PDFchevron_right
Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using Preclinical In Vitro and in Vivo Data
Handan He
Integrative Approaches in Drug Discovery and Development, 2014
View PDFchevron_right
Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data
M. Eichelbaum
European Journal of Clinical Pharmacology, 1982
View PDFchevron_right
Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats
KG sathish kg
European Journal of Pharmaceutical Sciences, 2011
View PDFchevron_right
Clinical application of the Mullen and Foster method for individualizing phenytoin dosage
Andrea Messori
The Italian Journal of Neurological Sciences, 1984
View PDFchevron_right